NCT07359326

Brief Summary

The aim of this thesis is to examine the effects of cold application on pain, disease activity, and quality of life in patients with Rheumatoid Arthritis. Currently, non-pharmacological interventions, such as cold therapy, are utilized less frequently than pharmacological treatments for the management of pain in inflamed joints. Cold application is anticipated to alleviate pain and consequently enhance patients' quality of life. This study seeks to improve quality of life by reducing pain in patients with Rheumatoid Arthritis. Given its simplicity, ease of application, and low cost, this intervention may be recommended as a pain management strategy both for patients and for nurses working in clinical settings. Furthermore, the study aims to contribute to the existing literature on the subject.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Dec 2024May 2026

Study Start

First participant enrolled

December 10, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 14, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 22, 2026

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2026

Expected
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

January 14, 2026

Last Update Submit

January 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rheumatoi Arthritis Disease Activity Index-5

    The Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5) is a patient-reported outcome measure designed to assess disease activity in individuals with rheumatoid arthritis

    3 weeks

Secondary Outcomes (1)

  • The Short Form Health Survery- SF-36

    3 weeks

Study Arms (2)

Cold Application Group

EXPERIMENTAL

Patients will be instructed to apply cold therapy three times daily for 15 minutes each session over a period of three weeks. Patients will report their daily cold application to the researcher via text message. For those unable to provide updates via text, the researcher will follow up daily by phone to monitor adherence to the intervention.

Behavioral: Cold Application

Control Group

NO INTERVENTION

This patient group will undergo follow-up assessment after a three-week period during which no intervention will be administered.

Interventions

Patients will be instructed to apply cold therapy three times daily for 15 minutes each session over a period of three weeks. Patients will report their daily cold application to the researcher via text message. For those unable to provide updates via text, the researcher will follow up daily by phone to monitor adherence to the intervention.

Cold Application Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with rheumatoid arthritis at least 6 months ago,
  • No problems with speaking, communicating, hearing, or understanding,
  • Able to understand and speak Turkish,
  • Experiencing pain.

You may not qualify if:

  • Patients who are in remission
  • Individuals of foreign nationality
  • People with psychiatric or mental illnesses
  • Patients who do not consent to participate in the study or who withdraw at any stage of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of health sciences Saglik Bilimleri University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainArthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 group with conventional therapy control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 14, 2026

First Posted

January 22, 2026

Study Start

December 10, 2024

Primary Completion

January 30, 2026

Study Completion (Estimated)

May 29, 2026

Last Updated

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations